Hyperinsulinemia may be targeted by diet alterations (68) or via re-positioning diabetes drugs such as the insulin-sensitizing drug metformin as adjuvant ADT therapy, to reduce circulating ligand levels (70) (Figure 8). This evidence concerns the gene INS and Hyperinsulinemia.